European Heart Journal

Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres, Elena Arbelo, Jeroen J Bax, Carina Blomstr?m-Lundqvist, Giuseppe Boriani, Manuel Castella, Gheorghe-Andrei Dan, Polychronis E Dilaveris, Laurent Fauchier, Gerasimos Filippatos, Jonathan M Kalman, Mark La Meir, Deirdre A Lane, Jean-Pierre Lebeau, Maddalena Lettino, Gregory Y H Lip, Fausto J Pinto, G Neil Thomas, Marco Valgimigli, Isabelle C Van Gelder, Bart P Van Putte, Caroline L Watkins, ESC Scientific Document Group

doi : 10.1093/eurheartj/ehaa612

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 373–498

خرید پکیج و مشاهده آنلاین مقاله

The year in cardiovascular medicine 2020: arrhythmias

Harry J G M Crijns, Frits Prinzen, Pier D Lambiase, Prashanthan Sanders, Josep Brugada

doi : 10.1093/eurheartj/ehaa1091

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 499–507

Summary of the progress in arrhythmias in 2020. RACE4 and ALL-IN indicated that integrated nurse-led care improves outcomes in AF patients.3,4 The same was reported for early rhythm control therapy15 and cryoablation as initial AF treatment.25,26 Subcutaneous ICD was non-inferior to classical transvenous ICD therapy in PRAETORIAN.54 One mechanistic study showed that autoantibodies against misexpressed actin, keratin, and connexin-43 proteins create a blood-borne biomarker profile enhancing diagnosis of Brugada syndrome.50 Another mechanistic study indicated that transseptal LV pacing yields similar improvement in contractility as His bundle pacing whilst being more easy to execute.44 In PRE-DETERMINE a simple-to-use ECG risk score improved risk prediction in patients with ischemic heart disease possibly enhancing appropriate ICD therapy in high risk patients.58

خرید پکیج و مشاهده آنلاین مقاله

Cardiac pacing in severe recurrent reflex syncope and tilt-induced asystole

Michele Brignole, Vincenzo Russo, Francesco Arabia, Mario Oliveira, Alonso Pedrote, Arnaud Aerts, Antonio Rapacciuolo, Serge Boveda, Jean Claude Deharo, Giampiero Maglia, Gerardo Nigro, Daniele Giacopelli, Alessio Gargaro, Marco Tomaino, for the BioSync CLS trial Investigators

doi : 10.1093/eurheartj/ehaa936

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 508–516

The benefit of cardiac pacing in patients with severe recurrent reflex syncope and asystole induced by tilt testing has not been established. The usefulness of tilt-table test to select candidates for cardiac pacing is controversial.

خرید پکیج و مشاهده آنلاین مقاله

Pacing for repeated vagal reflex-mediated syncope: an old problem with a solution

Cecilia Linde, Harry J G M Crijns

doi : 10.1093/eurheartj/ehaa975

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 517–519

خرید پکیج و مشاهده آنلاین مقاله

Ventricular arrhythmia burden during the coronavirus disease 2019 (COVID-19) pandemic

Catherine J O’Shea, Gijo Thomas, Melissa E Middeldorp, Curtis Harper, Adrian D Elliott, Noemi Ray, Dennis H Lau, Kevin Campbell, Prashanthan Sanders

doi : 10.1093/eurheartj/ehaa893

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 520–528

Our objective was to determine the ventricular arrhythmia burden in implantable cardioverter-defibrillator (ICD) patients during COVID-19.

خرید پکیج و مشاهده آنلاین مقاله

COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease

Giuseppe Boriani, Marco Vitolo

doi : 10.1093/eurheartj/ehaa958

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 529–532

خرید پکیج و مشاهده آنلاین مقاله

Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective

Sami O Simons, Adrian Elliott, Manuel Sastry, Jeroen M Hendriks, Michael Arzt, Michiel Rienstra, Jonathan M Kalman, Hein Heidbuchel, Stanley Nattel, Geertjan Wesseling, Ulrich Schotten, Isabelle C van Gelder, Frits M E Franssen, Prashanthan Sanders, Harry J G M Crijns, Dominik Linz

doi : 10.1093/eurheartj/ehaa822

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 532–540

Chronic obstructive pulmonary disease (COPD) is highly prevalent among patients with atrial fibrillation (AF), shares common risk factors, and adds to the overall morbidity and mortality in this population. Additionally, it may promote AF and impair treatment efficacy. The prevalence of COPD in AF patients is high and is estimated to be ?25%. Diagnosis and treatment of COPD in AF patients requires a close interdisciplinary collaboration between the electrophysiologist/cardiologist and pulmonologist. Differential diagnosis may be challenging, especially in elderly and smoking patients complaining of unspecific symptoms such as dyspnoea and fatigue. Routine evaluation of lung function and determination of natriuretic peptides and echocardiography may be reasonable to detect COPD and heart failure as contributing causes of dyspnoea. Acute exacerbation of COPD transiently increases AF risk due to hypoxia-mediated mechanisms, inflammation, increased use of beta-2 agonists, and autonomic changes. Observational data suggest that COPD promotes AF progression, increases AF recurrence after cardioversion, and reduces the efficacy of catheter-based antiarrhythmic therapy. However, it remains unclear whether treatment of COPD improves AF outcomes and which metric should be used to determine COPD severity and guide treatment in AF patients. Data from non-randomized studies suggest that COPD is associated with increased AF recurrence after electrical cardioversion and catheter ablation. Future prospective cohort studies in AF patients are needed to confirm the relationship between COPD and AF, the benefits of treatment of either COPD or AF in this population, and to clarify the need and cost-effectiveness of routine COPD screening.

خرید پکیج و مشاهده آنلاین مقاله

Valvular atrial fibrillation and a CHA2DS2-VASc score of 1—a statement of the ESC working group on cardiovascular pharmacotherapy and ESC council on stroke

Patrick Sulzgruber, Wolfram Doehner, Alexander Niessner

doi : 10.1093/eurheartj/ehaa1081

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 541–543

خرید پکیج و مشاهده آنلاین مقاله

Cardiac involvement in sarcoidosis and necessary ventricular tachycardia ablation

Christopher Schneeweis, Ingo Ahrens, Erol Saygili, Daniel Steven

doi : 10.1093/eurheartj/ehaa773

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Page 544

خرید پکیج و مشاهده آنلاین مقاله

ECG tracing during His pacing

Ying-Chieh Liao, Ju-Yi Chen

doi : 10.1093/eurheartj/ehaa912

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Page 545

خرید پکیج و مشاهده آنلاین مقاله

Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

doi : 10.1093/eurheartj/ehaa798

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Page 507

خرید پکیج و مشاهده آنلاین مقاله

Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

doi : 10.1093/eurheartj/ehaa945

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 546–547

خرید پکیج و مشاهده آنلاین مقاله

Corrigendum to: 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease

doi : 10.1093/eurheartj/ehaa835

European Heart Journal, Volume 42, Issue 5, 1 February 2021, Pages 548–549

خرید پکیج و مشاهده آنلاین مقاله